Production of Lentivirus particles pseudotyped with SARS-CoV-2 spike protein for neutralisation or drug antiviral activity assays. OH&RM [Internet]. 13 decembrie 2023 [citat 29 iulie 2026];:77. Disponibil la: https://www.journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/657